Please login to the form below

Not currently logged in
Email:
Password:

James Mond joins Absynth Biologics as chief medical officer

Will lead plans to develop vaccines and antibodies to tackle bacterial infections including MRSA

Absynth Biologics, the UK-based developer of vaccines and antibodies for bacterial infections, has appointed Dr James Mond as chief medical officer.

Dr Mond's previous experience in the vaccination industry includes working as a consultant to Virion Systems, where he oversaw development of a vaccine technology that was later licensed to GlaxoSmithKline (GSK).

Most recently, Dr Mond was executive vice president and chief scientific officer of Biosynexus, a biopharma company whose main focus was on developing a monoclonal antibody to prevent staphylococcal infections in children with a low birth weight.

At Absynth, Dr Mond will direct strategy and manage activities related to the company's vaccine and antibody programme to target staphylococcus aureus (S. Aureus), a bacteria whose strains include the antibiotic resistant infection MRSA.

“I am delighted to have someone of James' experience join Absynth at a time when we are reaching important milestones in our S. Aureus programmes and expect to see significant developments in building our R&D pipeline during the next few years,” said Fiona Marston, chief executive of Absynth.

29th May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics